日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Jannaschia sp. NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP639012JAAA
CSB-EP639012JAAA
CSB-BP639012JAAA
CSB-MP639012JAAA
CSB-EP639012JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP639013JAAA
CSB-EP639013JAAA
CSB-BP639013JAAA
CSB-MP639013JAAA
CSB-EP639013JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP639014JAAA
CSB-EP639014JAAA
CSB-BP639014JAAA
CSB-MP639014JAAA
CSB-EP639014JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Histidine--tRNA ligase (hisS), partial CSB-YP639015JAAA
CSB-EP639015JAAA
CSB-BP639015JAAA
CSB-MP639015JAAA
CSB-EP639015JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 30S ribosomal protein S16 (rpsP) CSB-YP639016JAAA
CSB-EP639016JAAA
CSB-BP639016JAAA
CSB-MP639016JAAA
CSB-EP639016JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Probable rRNA maturation factor (Jann_0703) CSB-YP639017JAAA
CSB-EP639017JAAA
CSB-BP639017JAAA
CSB-MP639017JAAA
CSB-EP639017JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP639018JAAA
CSB-EP639018JAAA
CSB-BP639018JAAA
CSB-MP639018JAAA
CSB-EP639018JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 50S ribosomal protein L6 (rplF) CSB-YP639019JAAA
CSB-EP639019JAAA
CSB-BP639019JAAA
CSB-MP639019JAAA
CSB-EP639019JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 50S ribosomal protein L16 (rplP) CSB-YP639020JAAA
CSB-EP639020JAAA
CSB-BP639020JAAA
CSB-MP639020JAAA
CSB-EP639020JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 30S ribosomal protein S10 (rpsJ) CSB-YP639021JAAA
CSB-EP639021JAAA
CSB-BP639021JAAA
CSB-MP639021JAAA
CSB-EP639021JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 50S ribosomal protein L10 (rplJ) CSB-YP639022JAAA
CSB-EP639022JAAA
CSB-BP639022JAAA
CSB-MP639022JAAA
CSB-EP639022JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP639023JAAA
CSB-EP639023JAAA
CSB-BP639023JAAA
CSB-MP639023JAAA
CSB-EP639023JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP639024JAAA
CSB-EP639024JAAA
CSB-BP639024JAAA
CSB-MP639024JAAA
CSB-EP639024JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP639025JAAA
CSB-EP639025JAAA
CSB-BP639025JAAA
CSB-MP639025JAAA
CSB-EP639025JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Thiamine import ATP-binding protein ThiQ (thiQ) CSB-YP639026JAAA
CSB-EP639026JAAA
CSB-BP639026JAAA
CSB-MP639026JAAA
CSB-EP639026JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Chaperone protein DnaJ (dnaJ) CSB-YP639027JAAA
CSB-EP639027JAAA
CSB-BP639027JAAA
CSB-MP639027JAAA
CSB-EP639027JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Protein-export protein SecB (secB) CSB-YP639028JAAA
CSB-EP639028JAAA
CSB-BP639028JAAA
CSB-MP639028JAAA
CSB-EP639028JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Light-independent protochlorophyllide reductase subunit B (bchB), partial CSB-YP639029JAAA
CSB-EP639029JAAA
CSB-BP639029JAAA
CSB-MP639029JAAA
CSB-EP639029JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Ribosome maturation factor RimP (rimP) CSB-YP639030JAAA
CSB-EP639030JAAA
CSB-BP639030JAAA
CSB-MP639030JAAA
CSB-EP639030JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila pseudoobscura pseudoobscura Serrate RNA effector molecule homolog (Ars2), partial CSB-YP639031DME
CSB-EP639031DME
CSB-BP639031DME
CSB-MP639031DME
CSB-EP639031DME-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×